JPMorgan Adjusts Flywire Corporation FLYW Rating to Neutral TDY Q1 2026 Earnings Strong EPS Beat Overshadowed by Missing Revenue Data and Stock Decline Healthcare Technology Innovations Pave the Way for a New Era of Personalized Medicine